Atta Systems Named a Top Healthcare Software Development Company of 2024 by Techreviewer.co
Techreviewer.co has recognized Atta Systems as one of the leading healthcare software development companies of 2024. This recognition follows a decade of work building MedTech products across medical imaging, dermatology, respiratory diagnostics, and virtual care—an external validation of the team’s continued focus on regulated healthcare software.
What Atta Systems builds in healthcare
Atta Systems builds custom software for MedTech companies and healthcare providers, with a focus on regulated products where compliance and clinical validation matter. Over the past decade, the team has contributed to several named deployments:
- Medicai: cloud medical imaging infrastructure for healthcare providers, with DICOM storage, browser-based viewing, secure sharing, and a Radiology AI Co-Pilot that assists radiologists with report drafting. Atta Systems contributed AI algorithms for early detection and radiologist co-pilot workflows.
- SkinVision: smartphone-based dermatology screening that assesses skin lesions for cancer risk using computer vision. CE-marked as a Class IIa medical device in the EU. Atta Systems built the iOS and Android apps, on-device image processing, and backend infrastructure.
- Eupnoos: a respiratory diagnostics platform analyzing breath sounds for early detection of respiratory conditions. Atta Systems contributed to the product development lifecycle, including signal processing and mobile implementation.
- Bold Health: a virtual care platform for gastrointestinal conditions, initially focused on Irritable Bowel Syndrome. Atta Systems built the full product architecture—patient mobile app, clinician web platform, and admin platform—running on AWS.
Regulatory and compliance track record
Healthcare software requires a specific regulatory and compliance posture depending on the product type and market. Atta Systems’ work spans the following frameworks:
| Framework | What It Covers | Where It Applies in Our Work |
|---|---|---|
| HIPAA | US patient data privacy and security for covered entities and their business associates. | Applies to products handling US protected health information (PHI), including Medicai’s US deployments. |
| GDPR | EU personal data protection, including health data as a special category requiring explicit consent. | Applies to all products processing data of EU residents, including Medicai EU deployments, SkinVision, and Bold Health. |
| CE marking (EU MDR) | EU medical device conformity under Regulation 2017/745. Class IIa or higher for most clinical decision software. | SkinVision holds CE marking as a Class IIa medical device. |
| FDA pathway | US medical device clearance or approval: 510(k), De Novo, or PMA depending on risk classification. | Products intended for US clinical use follow the appropriate FDA pathway based on intended use and risk. |
| ISO 27001 | International standard for information security management systems. | Applies to the infrastructure and operational practices used to build and deploy healthcare software. |
Areas of healthcare software work
The team’s healthcare software work spans five areas, with the case studies above serving as named examples of each:
- Telehealth and virtual care platforms. Bold Health is a virtual care platform for gastrointestinal conditions that connects patients with clinicians via a mobile app and a clinician web interface.
- Medical imaging and AI diagnostics. Medicai provides cloud-based medical imaging infrastructure with AI-assisted workflows for radiologists, including automated report drafting.
- Mobile diagnostic tools. SkinVision uses smartphone cameras and on-device computer vision for dermatology screening and operates as a CE-marked medical device in the EU.
- Respiratory diagnostics. Eupnoos applies signal processing to breath sounds captured through mobile devices for early detection of respiratory conditions.
- Electronic health records and interoperability. The team works on EHR integration points, including DICOM, HL7, and FHIR standards for clinical data exchange.
Looking ahead
The team continues to invest in three areas where MedTech requirements are evolving fastest:
- AI and machine learning, particularly around the regulatory implications of AI-enabled device software functions (AI-DSFs) under the FDA’s December 2024 final guidance on Predetermined Change Control Plans (PCCPs).
- Cloud-native architecture for healthcare, including FERPA and HIPAA-eligible configurations on AWS, GCP, and Azure, and data residency handling for EU deployments.
- Cybersecurity for connected medical devices, aligning with FDA premarket cybersecurity guidance and EU MDR cybersecurity requirements.
About the recognition
Techreviewer.co compiles annual rankings of software development companies by specialty, using a combination of client feedback, portfolio review, and published case studies. The 2024 healthcare list recognizes companies with demonstrated MedTech experience; the full list is available on Techreviewer’s ranking of healthcare software development companies.
The team is grateful to the clients who trusted Atta Systems with their healthcare products over the past decade, and to the Techreviewer.co review team for the recognition.
Related Articles
